CD31 and CD34 Expression as Immunohistochemical Markers of Endothelial Transdifferentiation in Human Cutaneous Melanoma

por Pisacane, A. M., Picciotto, F., Risio, M.
Publicado 2007

Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients

por Zugna, D, Senetta, R, Osella-Abate, S, Fierro, M T, Pisacane, A, Zaccagna, A, Sapino, A, Bataille, V, Maurichi, A, Picciotto, F, Cassoni, P, Quaglino, P, Ribero, S
Publicado 2018

Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer

por Capellero, S., Erriquez, J., Melano, C., Mesiano, G., Genta, S., Pisacane, A., Mittica, G., Ghisoni, E., Olivero, M., Di Renzo, M. F., Aglietta, M., Sangiolo, D., Valabrega, G.
Publicado 2020

High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients

por Berrino, E., Balsamo, A., Pisacane, A., Gallo, S., Becco, P., Miglio, U., Caravelli, D., Poletto, S., Paruzzo, L., Debernardi, C., Piccinelli, C., Zaccagna, A., Rescigno, P., Aglietta, M., Sapino, A., Carnevale-Schianca, F., Venesio, T.
Publicado 2021

CD44v6 as innovative sarcoma target for CAR-redirected CIK cells

por Leuci, V., Casucci, G. M., Grignani, G., Rotolo, R., Rossotti, U., Vigna, E., Gammaitoni, L., Mesiano, G., Fiorino, E., Donini, C., Pisacane, A., ambrosio, L. D., Pignochino, Y., Aglietta, M., Bondanza, A., Sangiolo, D.
Publicado 2018